Bicycle Therapeutics PLC
(NASDAQ:BCYC)
$14.10
0.23[1.66%]
Last update: 8:31AM (Delayed 15-Minutes)
Get Real Time Here
$14.10
0[0.00%]
After-Hours
Open13.870Close13.520
Vol / Avg.477.280K / 439.453KMkt Cap531.791M
Day Range13.520 - 14.44052 Wk Range12.540 - 33.400

Bicycle Therapeutics Stock (NASDAQ:BCYC), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$65.00

Lowest Price Target1

$30.00

Consensus Price Target1

$42.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
123000

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Morgan Stanley
  • B. Riley Securities
  • JMP Securities
  • Needham

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Bicycle Therapeutics

Upgrades (2)

Downgrades (1)

Initiations (8)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/08/2023BCYCBuy Now
Bicycle Therapeutics
$14.10360.99%Cantor Fitzgerald
Li Watsek
→ $65ReiteratesOverweight → OverweightGet Alert
11/03/2023BCYCBuy Now
Bicycle Therapeutics
$14.10183.69%Morgan Stanley
Jeffrey Hung
$42 → $40MaintainsEqual-WeightGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$14.10134.04%B. Riley Securities
Kalpit Patel
→ $33UpgradeNeutral → BuyGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$14.10360.99%Cantor Fitzgerald
Li Watsek
→ $65ReiteratesOverweight → OverweightGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$14.10212.06%JMP Securities
Reni Benjamin
→ $44ReiteratesMarket Outperform → Market OutperformGet Alert
09/12/2023BCYCBuy Now
Bicycle Therapeutics
$14.10226.24%Needham
Ami Fadia
→ $46ReiteratesBuy → BuyGet Alert
09/11/2023BCYCBuy Now
Bicycle Therapeutics
$14.10134.04%B. Riley Securities
Kalpit Patel
$33 → $33UpgradeNeutral → BuyGet Alert
09/07/2023BCYCBuy Now
Bicycle Therapeutics
$14.10360.99%Cantor Fitzgerald
Li Watsek
→ $65ReiteratesOverweight → OverweightGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$14.10197.87%Morgan Stanley
Jeffrey Hung
$42 → $42ReiteratesEqual-Weight → Equal-WeightGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$14.10212.06%JMP Securities
Reni Benjamin
$46 → $44MaintainsOutperformGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$14.10304.26%HC Wainwright & Co.
Swayampakula Ramakanth
→ $57ReiteratesBuy → BuyGet Alert
08/04/2023BCYCBuy Now
Bicycle Therapeutics
$14.10226.24%Needham
Ami Fadia
$48 → $46MaintainsBuyGet Alert
08/03/2023BCYCBuy Now
Bicycle Therapeutics
$14.10254.61%EF Hutton
Tony Butler
→ $50Reiterates → BuyGet Alert
05/11/2023BCYCBuy Now
Bicycle Therapeutics
$14.10226.24%JMP Securities
Reni Benjamin
$46 → $46ReiteratesMarket Outperform → Market OutperformGet Alert
05/08/2023BCYCBuy Now
Bicycle Therapeutics
$14.10290.07%Oppenheimer
Jay Olson
→ $55Reiterates → OutperformGet Alert
05/05/2023BCYCBuy Now
Bicycle Therapeutics
$14.10226.24%JMP Securities
Reni Benjamin
→ $46Reiterates → Market OutperformGet Alert
05/05/2023BCYCBuy Now
Bicycle Therapeutics
$14.10304.26%HC Wainwright & Co.
Swayampakula Ramakanth
→ $57Reiterates → BuyGet Alert
05/05/2023BCYCBuy Now
Bicycle Therapeutics
$14.10353.9%Needham
Ami Fadia
$67 → $64MaintainsBuyGet Alert
04/19/2023BCYCBuy Now
Bicycle Therapeutics
$14.10290.07%EF Hutton
Tony Butler
→ $55Reiterates → BuyGet Alert
Q

What is the target price for Bicycle Therapeutics (BCYC)?

A

The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by Cantor Fitzgerald on November 8, 2023. The analyst firm set a price target for $65.00 expecting BCYC to rise to within 12 months (a possible 360.99% upside). 28 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bicycle Therapeutics (BCYC)?

A

The latest analyst rating for Bicycle Therapeutics (NASDAQ: BCYC) was provided by Cantor Fitzgerald, and Bicycle Therapeutics reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Bicycle Therapeutics (BCYC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bicycle Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bicycle Therapeutics was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.

Q

Is the Analyst Rating Bicycle Therapeutics (BCYC) correct?

A

While ratings are subjective and will change, the latest Bicycle Therapeutics (BCYC) rating was a reiterated with a price target of $0.00 to $65.00. The current price Bicycle Therapeutics (BCYC) is trading at is $14.10, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.